VelosBio
is a biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of cancer... Read moreVelosBio
is a biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of cancer... Read more
News
Dec 18, 2020
MarketScreener
VelosBio: Arix Bioscience : Completion of sale of VelosBio
Nov 15, 2020
San Diego Business Journal
VelosBio: Merck Buys VelosBio for $2.75 Billion
Nov 10, 2020
Wall Street PR
VelosBio: Merck & Co Inc. (NYSE:MRK) Bolstering Its Oncology Pipeline With Acquisition Of VelosBio
Nov 10, 2020
ChinaBio Today
VelosBio: Exclusive: Decheng's Inside View of Merck's $2.75 Billion Acquisition of VelosBio
Nov 09, 2020
Pulse2.0
VelosBio: Why Merck (MRK) Is Buying VelosBio For $2.75 Billion In Cash
Nov 06, 2020
Philadelphia Citybizlist
VelosBio: Merck Makes a $2.8 Billion Bet on an Experimental New Cancer Drug
Nov 06, 2020
FinSMEs
VelosBio: Merck to Acquire VelosBio, for $2.75 Billion
Nov 06, 2020
WRAL TechWire
VelosBio: Pappas Capital makes one of its 'most successful exits' in Merck $2.75B deal for startup
Nov 05, 2020
PharmaLive
VelosBio: Merck to bolster cancer drug portfolio with VelosBio $2.75 billion deal
Nov 05, 2020
BioSpace
VelosBio: Merck Snaps Up VelosBio and its ROR1 Inhibitor in $2.75 Billion Deal
VelosBio Competitors
1
2
3
4
5
6
7
8
9
10